Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.

•Costs of AML therapy in the first year for privately insured patients aged 50 to 64 years were investigated.•As expected, total costs were lower for patients receiving chemotherapy alone.•Limitations of administrative claims data preclude direct comparisons between therapies.